Education
About Us
Working with TipRanks
Follow Us
Livzon Pharmaceutical Group Class H (HK:1513)
OTHER OTC:1513
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 11.81B | ¥ 12.43B | ¥ 12.63B | ¥ 12.06B | ¥ 10.52B |
| Gross Profit | ¥ 7.73B | ¥ 7.66B | ¥ 8.17B | ¥ 7.81B | ¥ 6.85B |
| Operating Income | ¥ 2.84B | ¥ 2.42B | ¥ 2.35B | ¥ 2.27B | ¥ 2.50B |
| EBITDA | ¥ 3.47B | ¥ 3.33B | ¥ 3.08B | ¥ 2.77B | ¥ 2.91B |
| Net Income | ¥ 2.06B | ¥ 1.95B | ¥ 1.91B | ¥ 1.78B | ¥ 1.71B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 10.92B | ¥ 11.41B | ¥ 10.52B | ¥ 9.33B | ¥ 9.98B |
| Total Assets | ¥ 24.46B | ¥ 25.04B | ¥ 24.86B | ¥ 22.37B | ¥ 20.59B |
| Total Debt | ¥ 3.93B | ¥ 3.48B | ¥ 3.62B | ¥ 2.69B | ¥ 1.93B |
| Net Debt | ¥ -6.89B | ¥ -7.84B | ¥ -6.79B | ¥ -6.45B | ¥ -8.02B |
| Total Liabilities | ¥ 9.55B | ¥ 10.28B | ¥ 9.93B | ¥ 8.06B | ¥ 6.95B |
| Stockholders' Equity | ¥ 13.86B | ¥ 14.04B | ¥ 13.88B | ¥ 13.00B | ¥ 12.11B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 2.41B | ¥ 2.43B | ¥ 1.83B | ¥ 593.23M | ¥ 1.51B |
| Operating Cash Flow | ¥ 2.98B | ¥ 3.25B | ¥ 2.77B | ¥ 1.90B | ¥ 2.16B |
| Investing Cash Flow | ¥ -660.33M | ¥ -708.37M | - | - | - |
| Financing Cash Flow | ¥ -2.49B | - | - | - | - |